Functional ability and physical and psychosocial well-being of hypermobile schoolchildren.

OBJECTIVE To compare the functional ability and the physical and psychosocial well-being of children with joint hypermobility to those of age- and sex-matched non-hypermobile subjects. METHODS 311 healthy Italian schoolchildren aged 6.3 to 19.3 years were examined for hypermobility of the joints. Functional ability was assessed through the Childhood Health Assessment Questionnaire (CHAQ) and the physical and psychosocial well-being through the Childhood Health Questionnaire (CHQ). The parent's assessment of the child's overall well-being and of the child's pain was measured on a visual analogue scale. RESULTS The overall prevalence of articular hypermobility was 34% (106/311), with the median hypermobility score being 3 (interquartile range 1, 5). Although the hypermobility score of girls (median 3: interquartile range 2, 5) exceeded that of boys (median 2.5; interquartile range 0, 5), this difference was not statistically significant (p = 0.16). The level of hypermobile children's pain in the preceding weeks, as assessed by the parents, was comparable to that recorded in the non-hypermobile peers. There was a weak negative correlation between the hypermobility score and the age of the child (r = -0.14, p=0.01). All instrument scores were comparable between hypermobile and non-hypermobile subjects, with the sole exception of a borderline significant greater impairment of the Role/social limitations-physical subscale of the CHQ in the hypermobile group. The hypermobility score was not correlated with any instrument score. CONCLUSIONS The presence of joint hypermobility does not affect the functional ability and the physical and psychosocial well being of otherwise healthy children. These results suggest that the physical functioning in everyday life and the general health status of hypermobile children are not impaired.

[1]  T. Arasıl,et al.  The prevalence of joint hypermobility among high school students , 2005, Rheumatology International.

[2]  P. Helders,et al.  Pediatric generalized joint hypermobility with and without musculoskeletal complaints: a localized or systemic disorder? , 2003, Pediatrics.

[3]  S. Cavuto,et al.  The Italian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). , 2001, Clinical and experimental rheumatology.

[4]  S. Cavuto,et al.  Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. , 2001, Clinical and experimental rheumatology.

[5]  S. Gurley-Green Living with the hypermobility syndrome. , 2001, Rheumatology.

[6]  P. Woo,et al.  Benign joint hypermobility in childhood. , 2001, Rheumatology.

[7]  R. Grahame,et al.  The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). , 2000, The Journal of rheumatology.

[8]  H. Jonsson,et al.  Articular hypermobility in Icelandic 12-year-olds. , 1999, Rheumatology.

[9]  A. El-Garf,et al.  Hypermobility among Egyptian children: prevalence and features. , 1998, The Journal of rheumatology.

[10]  J. Salminen,et al.  Joint Hypermobility Is Not a Contributing Factor to Musculoskeletal Pain in Pre‐Adolescents , 1996, The Journal of rheumatology.

[11]  K. Janaki,et al.  Joint hypermobility in south Indian children. , 1996, Indian pediatrics.

[12]  J. Press,et al.  Articular symptoms in hypermobile schoolchildren: a prospective study. , 1991, The Journal of pediatrics.

[13]  E. Giannini,et al.  Arthritis/arthralgia and hypermobility of the joints in schoolchildren. , 1988, The Journal of rheumatology.

[14]  J. Baum,et al.  The hypermobility syndrome. , 1983, Pediatrics.

[15]  P. Beighton,et al.  Articular mobility in an African population. , 1973, Annals of the rheumatic diseases.

[16]  C CARTER,et al.  PERSISTENT JOINT LAXITY AND CONGENITAL DISLOCATION OF THE HIP. , 1964, The Journal of bone and joint surgery. British volume.

[17]  L. Terracciano,et al.  HER2 breast cancer therapies: a review , 2009, Biologics : targets & therapy.